LRP6-mediated Wnt/β-catenin signaling defects are essential in regulating synaptic function, blood–brain barrier function, and amyloid protein accumulation in AD (Liu et al., 2014; Wang et al., 2022a). Here, LRP6 is linked to Alzheimer disease.